L-Buthionine sulfoximine CAS: 83730-53-4
MF: C8H18N2O3S
MW: 222.30
A glutathione-synthesis inhibitor that activates oxidative stress.

L-Buthionine sulfoximine (CAS 83730-53-4)

L-Buthionine sulfoximine | CAS 83730-53-4 is rated 5.0 out of 5 by 1.
  • y_2020, m_3, d_28, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200824, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 127ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Synonym: L-BSO
Application: A glutathione-synthesis inhibitor that activates oxidative stress
CAS Number: 83730-53-4
Purity: ≥97%
Molecular Weight: 222.30
Molecular Formula: C8H18N2O3S
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Buthionine-sulfoximine (BSO) is a glutathione-synthesis inhibitor that activates oxidative stress through irreversibly inhibiting γ-GCSc (γ-glutamylcysteine synthetase). Studies show methylglyoxal (MG) activated caspase-3 is enhanced in the presence of BSO. It has been reported that BSO can augment HIV-1 activation through class I HDACIs, and that it can sensitize human breast cancer cells that are anti-hormone resistant to estrogen-induced apoptosis.


References

1. Reliene, R., et al. 2006. Carcinogenesis. 27: 240-244. PMID: 16162646
2. Lewis-Wambi, J.S., et al. 2008. Breast Cancer Res. 10: R104. PMID: 19061505
3. Han, Y.H., et al. 2009. Int. J. Mol. Med. 24: 261-268. PMID: 19578799
4. Savarino, A., et al. 2009. Retrovirology. 6: 52. PMID: 19486542
5. Takahashi, K., et al. 2010. Biol. Pharm. Bull. 33: 556-560. PMID: 20410585

Physical State :
Solid
Solubility :
Soluble in water (>25 mg/mL), aqueous acid, and 1N HCl.
Storage :
Store at -20° C
Melting Point :
224-226° C
Boiling Point :
~382.3° C at 760 mmHg (Predicted)
Density :
~1.3 g/cm3 (Predicted)
Refractive Index :
n20D 1.54
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
EK7713440
PubChem CID :
119565
MDL Number :
MFCD00067000
Beilstein Registry :
2367136
SMILES :
CCCCS(=N)(=O)CC[[email protected]@H](C(=O)O)N

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

L-Buthionine sulfoximine  Product Citations

See how others have used L-Buthionine sulfoximine. Click on the entry to view the PubMed entry .

Citations 1 to 10 of 17 total

PMID: # 31273592  Wang, J.|Wu, D.|Zhang, J.|Liu, H.|Wu, J.|Dong, W.| et al. 2019. Dig. Dis. Sci.

PMID: # 29363570  Cao, Y. et al. 2018. Reproduction. 155: 307-319.

PMID: # 30014903  Shen, M. et al. 2018. Redox Biol. 18: 138-157.

PMID: # 27554969  Banerjee, S. et al. 2016. Free Radic. Biol. Med. 99: 296-307.

PMID: # 27374085  Vittorio, O. et al. 2016. Oncotarget.

PMID: # 25567281  Reniere, ML. et al. 2015. Nature. 517: 170-3.

PMID: # 25875358  Fischer, MJ. et al. 2015. PloS one. 10: e0123762.

PMID: # 26446958  Le Gal, K. et al. 2015. Sci Transl Med. 7: 308re8.

PMID: # 23255485  Zhai, X. et al. 2013. Molecular nutrition & food research. 57: 249-59.

PMID: # 23426973  Maryon, EB. et al. 2013. Am. J. Physiol., Cell Physiol. 304: C768-79.

Citations 1 to 10 of 17 total

do you have bulk pricing available 

Asked by: adam wisnew
Thank you for your interest in this product (sc-200824). We are happy to provide you with a quote for a bulk purchase. Please contact our Special Orders Department by email, [email protected] Or by phone, 800-457-3801 option 2 for Technical Support, and ask to speak with one of our Special Orders Coordinators. If you wish to request a quote directly through our website, please connect with us using our Live Chat!
Answered by: Technical Support
Date published: 2016-09-13
  • y_2020, m_3, d_28, h_16CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_200824, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 134ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Faundez Faundez, et. al. (PubMed ID 18332173) found that by treating Trypanosoma cruzi infected mice with L-Buthionine sulfoximine (BSO) at a dose of 220mg/kg of body weight per day, the survival rate improved and the parasitemias and parasite burden on the heart was decreased. -SCBT Publication Review
Date published: 2015-06-27
  • y_2020, m_3, d_28, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200824, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 10ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.